Nanotherapy effective in mice with multiple myeloma

Saint-Louis: Researchers have designed a nanoparticle-based therapy that is effective in treating mice with multiple myeloma, a cancer of immune cells in the bone marrow. Targeted specifically to the malignant cells, these nanoparticles protect their therapeutic cargo from degradation in the bloodstream and greatly enhance drug delivery into the cancer cells. These are longtime hurdles in the development of this class of potential cancer drugs. The study, by researchers at Washington University School of Medicine in St. Louis, appears online in the journal Molecular Cancer Therapy.

FDA approves Farydak for treatment of multiple myeloma

FDA. US: The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma.